# C4 Therapeutics (CCCC) — Earnings

CCCC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cccc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.37 |
| EPS estimate | −$0.38 |
| EPS surprise | +3.65% |
| Revenue surprise | −1.33% |
| Revenue | $6.5M |
| Revenue estimate | $6.5M |
| Reported | Aug 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1662579/000162828025038587/cccc-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 7, 2025 | −$0.38 | −$0.37 | 3.65% | $6.5M | $6.5M |
| Q1 2025 | May 7, 2025 | −$0.44 | −$0.37 | 16.29% | $4.5M | $7.2M |
| Q4 2024 | Feb 27, 2025 | −$0.49 | −$0.49 | 0.63% | $5.1M | $5.2M |
| Q3 2024 | Oct 31, 2024 | −$0.38 | −$0.35 | 7.65% | $5.9M | $15.4M |
| Q2 2024 | Aug 1, 2024 | −$0.36 | −$0.26 | 28.65% | $4.8M | $12.0M |
| Q1 2024 | May 8, 2024 | −$0.36 | −$0.41 | -12.36% | $12.0M | $3.0M |

## Frequently Asked Questions

### When did C4 Therapeutics (CCCC) last report earnings?

C4 Therapeutics last reported on Aug 7, 2025, covering fiscal Q2 2025.

### Did CCCC beat earnings estimates?

Yes. C4 Therapeutics reported EPS of −$0.37 for Q2 2025 against a −$0.38 estimate — a 3.65% beat.

### How much revenue did CCCC report last quarter?

C4 Therapeutics reported $6.5M in revenue for Q2 2025, against a consensus estimate of $6.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).